Showing results (741-750 of 767) with videos related to

Sort By:
Pageof 77
Iscience|October 10, 2022
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2Phillip Pymm, Samuel J Redmond, Olan Dolezal, et al.
Cell|July 11, 2025
Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivoJames P Cooney, Ashley Hirons, Natasha Jansz, et al.
Nature Communications|June 15, 2026
Efferocytosis of apoptotic bodies drives SARS-CoV-2 infection and macrophage inflammationThanh Kha Phan, Dylan Sheerin, Bo Shi, et al.
Mabs|April 19, 2023
"Stapling" scFv for multispecific biotherapeutics of superior propertiesLauren E Boucher, Elisabeth Geyer Prinslow, Michael Feldkamp, et al.
Journal of Biotechnology|November 22, 2011
Optimization of erythropoietin production with controlled glycosylation-PEGylated erythropoietin produced in glycoengineered Pichia pastorisJuergen H Nett, Sujatha Gomathinayagam, Stephen R Hamilton, et al.
Open Forum Infectious Diseases|November 16, 2022
Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral SheddingSujata Mathur, Michelle C Davidson, Khamal Anglin, et al.
Molecular Therapy. Methods & Clinical Development|December 17, 2024
mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprintingHareth A Al-Wassiti, Stewart A Fabb, Samantha L Grimley, et al.
NPJ Vaccines|January 17, 2026
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59Linda Earnest, Daniel Fernandez Ruiz, Melissa A Edeling, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2022
Magnitude and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission: A Longitudinal Cohort StudyJ Daniel Kelly, Scott Lu, Khamal Anglin, et al.
JCI Insight|March 10, 2025
Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infectionsMiguel A Garcia-Knight, J Daniel Kelly, Scott Lu, et al.
Pageof 77